Pennant Group (PNTG) Stock Price

Pennant Group Price

NASDAQ·CLOSED
39.39USD+0.39 (+1.00 %)
Market closed

Revenue has compounded at 17.8% per year over the past 9 years to 947.71 M USD. Earnings per share have grown at 11.4% per year over the last 8 years. Pennant Group's net margin stands at 3.1%, up from 0.6% several years earlier. Analysts set a median price target of 38.25 USD, implying 2.9% below the current price. Of 13 analysts, 12 rate the stock a buy — an overall Buy consensus. The stock trades about 68% above its 52-week low.

Pennant Group stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Pennant Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Pennant Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Pennant Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Pennant Group Stock Price History
DatePennant Group Price
8/10/202639.39 USD
8/7/202639.00 USD
8/6/202639.06 USD
8/5/202638.69 USD
8/4/202639.12 USD
8/3/202640.18 USD
7/31/202640.32 USD
7/30/202641.13 USD
7/29/202641.61 USD
7/27/202641.73 USD
7/23/202639.81 USD
7/22/202640.45 USD
7/21/202641.47 USD
7/20/202641.15 USD
7/17/202641.95 USD
7/16/202641.71 USD
7/15/202640.07 USD
7/14/202639.76 USD
7/13/202640.45 USD
7/10/202640.50 USD
7/9/202640.46 USD
7/8/202639.35 USD
7/7/202639.70 USD
7/6/202639.44 USD
7/2/202638.52 USD
7/1/202637.36 USD
6/30/202636.95 USD
6/29/202635.69 USD
6/26/202635.91 USD
6/25/202635.85 USD
6/24/202634.58 USD
6/23/202634.23 USD
6/22/202633.95 USD
6/18/202633.57 USD
6/17/202634.05 USD
6/16/202633.88 USD
6/15/202633.00 USD
6/12/202632.97 USD
6/11/202632.07 USD
6/10/202633.13 USD
6/9/202632.77 USD
6/8/202631.38 USD
6/5/202631.80 USD
6/4/202630.18 USD
6/3/202630.58 USD
6/2/202630.73 USD
6/1/202631.60 USD
5/29/202633.93 USD
5/28/202633.76 USD
5/27/202633.87 USD
5/26/202633.44 USD
5/22/202634.35 USD
5/21/202634.66 USD
5/20/202635.03 USD
5/19/202634.98 USD
5/18/202635.34 USD
5/15/202635.55 USD
5/14/202636.90 USD
5/13/202635.59 USD
5/12/202635.42 USD
5/11/202634.13 USD
5/8/202635.90 USD
5/7/202635.73 USD
5/6/202632.53 USD
5/4/202631.10 USD
5/1/202631.30 USD
4/30/202631.32 USD
4/29/202630.71 USD
4/28/202630.79 USD
4/27/202630.89 USD
4/24/202630.01 USD
4/23/202630.11 USD
4/22/202629.37 USD
4/21/202628.90 USD
4/20/202629.64 USD
4/17/202630.74 USD
4/16/202630.42 USD
4/15/202630.54 USD
4/14/202630.65 USD
4/13/202631.32 USD
4/10/202630.68 USD
4/9/202631.67 USD
4/8/202631.01 USD
4/7/202630.55 USD
4/6/202630.00 USD
4/2/202629.66 USD
4/1/202630.35 USD
3/31/202630.48 USD
3/30/202630.14 USD
3/27/202629.84 USD
3/26/202630.56 USD
3/25/202631.11 USD
3/24/202631.02 USD
3/23/202631.37 USD
3/20/202631.05 USD
3/19/202632.06 USD
3/18/202632.06 USD
3/17/202633.03 USD
3/16/202633.49 USD
3/13/202632.89 USD
3/12/202633.63 USD
3/11/202634.02 USD
3/10/202634.05 USD
3/9/202634.44 USD
3/6/202633.66 USD
3/5/202633.30 USD
3/4/202633.54 USD
3/3/202633.02 USD
3/2/202633.82 USD
2/27/202633.71 USD
2/26/202630.44 USD
2/25/202633.09 USD
2/24/202631.98 USD
2/23/202632.56 USD
2/20/202632.32 USD
2/19/202632.35 USD
2/18/202632.65 USD
2/17/202631.85 USD
2/13/202631.97 USD
2/12/202631.16 USD
2/11/202631.61 USD
2/10/202630.97 USD
2/9/202630.80 USD
2/6/202630.35 USD
2/5/202629.98 USD
2/4/202628.92 USD
2/3/202629.22 USD
2/2/202628.22 USD
1/30/202627.62 USD
1/29/202627.34 USD
1/28/202627.49 USD
1/27/202627.16 USD
1/26/202630.54 USD
1/23/202630.53 USD
1/22/202631.16 USD
1/21/202630.00 USD
1/20/202629.30 USD
1/16/202629.15 USD
1/15/202629.90 USD
1/14/202628.82 USD
1/13/202628.75 USD
1/12/202628.86 USD
1/9/202628.13 USD
1/8/202629.10 USD
1/7/202628.90 USD
1/6/202628.59 USD
1/5/202628.40 USD
1/2/202627.83 USD
12/31/202528.15 USD
12/30/202528.80 USD
12/29/202529.23 USD
12/26/202529.05 USD
12/24/202529.23 USD
12/23/202529.36 USD
12/22/202529.45 USD
12/19/202529.34 USD
12/18/202529.36 USD
12/17/202529.39 USD
12/16/202529.73 USD
12/15/202529.73 USD
12/12/202529.72 USD
12/11/202529.51 USD
12/10/202529.07 USD
12/9/202528.90 USD
12/8/202528.82 USD
12/5/202529.21 USD
12/4/202528.94 USD
12/3/202529.08 USD
12/2/202529.27 USD
12/1/202528.40 USD
11/28/202527.70 USD
11/26/202528.09 USD
11/25/202528.07 USD
11/24/202526.80 USD
11/21/202526.67 USD
11/20/202525.91 USD
11/19/202526.16 USD
11/18/202526.09 USD
11/17/202525.40 USD
11/14/202524.90 USD
11/13/202524.89 USD
11/12/202525.25 USD
11/11/202525.26 USD
11/10/202524.60 USD
11/7/202525.54 USD
11/6/202523.75 USD
11/5/202525.17 USD
11/4/202525.28 USD
11/3/202525.05 USD
10/31/202524.73 USD
10/30/202524.61 USD
10/29/202525.03 USD
10/28/202525.89 USD
10/27/202525.26 USD
10/24/202525.48 USD
10/23/202524.48 USD
10/22/202524.98 USD
10/21/202524.03 USD
10/20/202524.00 USD
10/17/202523.65 USD
10/16/202523.91 USD
10/15/202524.24 USD
10/14/202524.07 USD
10/13/202523.99 USD
10/10/202524.36 USD
10/9/202525.04 USD
10/8/202525.29 USD
10/7/202525.01 USD
10/6/202525.52 USD
10/3/202525.86 USD
10/2/202525.57 USD
10/1/202525.40 USD
9/30/202525.22 USD
9/29/202525.18 USD
9/28/202525.18 USD
9/25/202525.40 USD
9/24/202524.55 USD
9/23/202524.50 USD
9/22/202524.58 USD
9/19/202524.20 USD
9/18/202524.76 USD
9/17/202524.36 USD
9/16/202524.63 USD
9/15/202525.20 USD
9/12/202525.59 USD
9/11/202525.71 USD
9/10/202524.60 USD
9/9/202524.83 USD
9/8/202524.51 USD
9/5/202524.30 USD
9/4/202524.08 USD
9/3/202524.69 USD
9/2/202523.96 USD
8/29/202524.13 USD
8/28/202524.29 USD
8/27/202524.49 USD
8/26/202524.27 USD
8/25/202524.64 USD
8/22/202525.06 USD
8/21/202524.75 USD
8/20/202525.16 USD
8/19/202525.00 USD
8/18/202525.11 USD
8/15/202525.30 USD
8/14/202524.70 USD
8/13/202526.08 USD
8/12/202526.80 USD
Access this data via the Eulerpool API
Get Free API Key

Pennant Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
439.69 M USD
4.70 M USD
2.70 M USD
Jan 1, 2022
473.24 M USD
16.56 M USD
6.64 M USD
Jan 1, 2023
544.89 M USD
25.17 M USD
13.38 M USD
Jan 1, 2024
695.24 M USD
38.12 M USD
22.56 M USD
Jan 1, 2025
947.71 M USD
51.39 M USD
29.58 M USD
Jan 1, 2026 (e)
1.17 B USD
45.36 M USD
46.94 M USD
Jan 1, 2027 (e)
1.26 B USD
48.90 M USD
55.41 M USD
Jan 1, 2028 (e)
1.31 B USD
51.09 M USD
64.24 M USD

Pennant Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 12, 2026, 6:02 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
20162017201820192020202120222023202420252026e2027e2028e
0.220.250.290.340.390.440.470.540.700.951.171.261.31
–15.2114.4018.1815.3812.567.7415.0127.7636.2623.027.814.46
12.9012.8014.6913.0213.8510.9312.2612.3213.3812.8812.8812.8812.88
28.0032.0042.0044.0054.0048.0058.0067.0093.00122.00150.08161.81169.02
12.0015.0020.005.0018.004.0016.0025.0038.0051.0045.0048.0051.00
5.536.006.991.484.620.913.384.605.475.393.863.823.89
7.009.0015.002.0015.002.006.0013.0022.0029.0046.0055.0064.00
–28.5766.67-86.67650.00-86.67200.00116.6769.2331.8258.6219.5716.36
35.4428.0028.0027.8530.7428.5330.0930.2435.3335.4435.4435.4435.44
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Pennant Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Pennant Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Pennant Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Pennant Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Pennant Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Pennant Group stock margins

The Pennant Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Pennant Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Pennant Group.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
11.05 %
1.07 %
0.61 %
Jan 1, 2022
12.38 %
3.50 %
1.40 %
Jan 1, 2023
12.30 %
4.62 %
2.46 %
Jan 1, 2024
13.49 %
5.48 %
3.24 %
Jan 1, 2025
12.92 %
5.42 %
3.12 %
Jan 1, 2026 (e)
12.92 %
3.89 %
4.03 %
Jan 1, 2027 (e)
12.92 %
3.89 %
4.41 %
Jan 1, 2028 (e)
12.92 %
3.89 %
4.89 %

Pennant Group Stock Revenue, EBIT, Earnings per Share

The Pennant Group earnings per share therefore indicates how much revenue Pennant Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
15.41 USD
0.16 USD
0.09 USD
Jan 1, 2022
15.73 USD
0.55 USD
0.22 USD
Jan 1, 2023
18.02 USD
0.83 USD
0.44 USD
Jan 1, 2024
19.68 USD
1.08 USD
0.64 USD
Jan 1, 2025
26.74 USD
1.45 USD
0.83 USD
Jan 1, 2026 (e)
33.62 USD
1.28 USD
1.35 USD
Jan 1, 2027 (e)
36.25 USD
1.38 USD
1.60 USD
Jan 1, 2028 (e)
37.88 USD
1.44 USD
1.85 USD

Pennant Group business model & stock analysis

The Pennant Group Inc is a healthcare company based in Eagle, Idaho. It was established in 2019 as an independent company by taking over Vantage Healthcare. The company offers a wide range of services focusing on the needs of patients and care facilities. History: The Pennant Group was founded in 2019 as an independent company by the former employees of Vantage Health Services. The company was then listed on the NASDAQ stock exchange. The founders have extensive experience in the industry and have also focused on innovative solutions and technologies to improve healthcare and modernize the industry as a whole. Business model: The business model of Pennant Group Inc is focused on healthcare and nursing services. It provides specialized services for elderly individuals and those in need of long-term care. These services include rehabilitative therapy, home and facility-based care, hospice and palliative care, and much more. The company also serves patients with mental or behavioral health issues. Different segments: Pennant Group is a versatile company and offers a wide range of services. The different segments include nursing centers, hospice and palliative care services, home care, and a comprehensive range of rehabilitation services such as physical therapy, occupational therapy, and speech therapy. Nursing centers: The nursing centers of Pennant Group offer a wide range of services for elderly individuals and those in need of long-term care. They can receive care in nursing homes or assisted living facilities. The facilities offer various types of care, including short-term care, long-term care, rehabilitation, and reintegration. Hospice and palliative care services: Pennant Group's hospice and palliative care services provide support and care for patients with life-threatening illnesses. They are attended by experienced physicians, nurses, and other healthcare providers. Palliative care focuses on pain management and symptom relief, while hospice services provide planning and coordination of care for patients in their final phase of life. Home care: Pennant Group's home care provides supervised assistance to elderly individuals and people with disabilities. The service includes nursing care, therapy, and support for daily living. Home care is often directed towards patients who require rehabilitation after a hospital stay or surgery. Rehabilitation services: Pennant Group's rehabilitation services encompass a wide range of medical services, such as physical therapy, occupational therapy, and speech therapy. The services are aimed at patients of all ages and are specialized in restoring the mobility and independence of the patients. Products: Pennant Group does not offer specific product services but focuses on providing services. However, the company has made some initial investments in innovative technologies and services, such as the development of virtual caregiving services to enhance patient experience and care efficiency. In summary, the Pennant Group Inc is an emerging healthcare company that offers a wide range of services to improve the care and treatment of elderly individuals and patients with special needs. The company's business model focuses on specialized care, rehabilitation services, a comprehensive hospice and palliative care program, and innovative technologies. The establishment of Pennant Group represents a significant step in the modernization of healthcare.

Pennant Group SWOT Analysis

Strengths

1. Solid Financial Performance: Pennant Group Inc has consistently demonstrated strong financial performance, with steady revenue growth and healthy profitability.

2. Strong Market Position: The company has established a strong presence in the healthcare industry, with a wide range of services and a growing customer base.

3. Diversified Service Offerings: Pennant Group Inc offers a diverse portfolio of healthcare services, including home health, hospice, and senior living. This diversification helps mitigate risks and ensures multiple revenue streams.

Weaknesses

1. Dependence on Government Reimbursements: The company's revenue heavily relies on government reimbursements, making it vulnerable to changes in healthcare policies and regulations.

2. Geographic Concentration: Pennant Group Inc primarily operates in a few specific regions, which exposes it to localized economic factors and regulatory changes in those areas.

3. Limited International Presence: The company's operations are primarily focused within the United States, limiting its exposure to global markets and potential international growth opportunities.

Opportunities

1. Aging Population: The increasing elderly population in the United States presents a significant growth opportunity for Pennant Group Inc, as demand for healthcare services is expected to rise.

2. Technological Advancements: Embracing and leveraging technology advancements in the healthcare sector can enhance service delivery, improve operational efficiency, and provide a competitive edge.

3. Strategic Partnerships: Collaborating with hospitals, healthcare systems, and other related organizations can help expand Pennant Group Inc's reach and access to potential customers.

Threats

1. Intense Competition: The healthcare industry is highly competitive, with numerous players offering similar services. Pennant Group Inc faces the risk of losing market share to competitors.

2. Regulatory Environment: Constant changes in healthcare regulations and compliance requirements pose a challenge to the company's operations, potentially leading to increased costs and operational complexities.

3. Workforce Shortages: There is a shortage of skilled healthcare professionals in many regions, which could impact Pennant Group Inc's ability to provide quality services and expand its workforce.

Pennant Group Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Pennant Group Employees
Details
Date
Pennant Group Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Pennant Group Segments

Pennant Group Revenue by Segment

  • 3 Years

  • 5 Years

  • Max

Home Health and Hospice Services
Senior Living Services
Details
Date
Home Health and Hospice Services
Senior Living Services
Jan 1, 2019
105.68 M USD
131.91 M USD
Jan 1, 2020
134.08 M USD
137.29 M USD
Jan 1, 2021
151.61 M USD
130.12 M USD
Jan 1, 2022
160.52 M USD
130.99 M USD
Jan 1, 2024
240.10 M USD
175.76 M USD
Jan 1, 2025
317.80 M USD
214.98 M USD

Pennant Group Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Pennant Group historical P/E ratio, EBIT multiple, and P/S ratio

Pennant Group annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Pennant Group shares outstanding

The number of shares of Pennant Group was 35.44 M in 2025. This indicates how many shares Pennant Group is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
28.53 M Stocks
Jan 1, 2022
30.09 M Stocks
Jan 1, 2023
30.24 M Stocks
Jan 1, 2024
35.33 M Stocks
Jan 1, 2025
35.44 M Stocks
Jan 1, 2026 (e)
35.44 M Stocks
Jan 1, 2027 (e)
35.44 M Stocks
Jan 1, 2028 (e)
35.44 M Stocks

Current Pennant Group forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
1.35 %
Buy
92.31 % (12)
Hold
7.69 % (1)
Sell
0.00 % (0)
12M Price Target
38.25
Last Price
39.39
Currency
USD
12M Return Potential
-2.89 %
LTM Return
0 %

Pennant Group Analyst Rating Actions

DateFirmActionRatingReliability
7/14/2026
Truist Securities
Truist Securities
MaintainedBuy–
7/13/2026
Wells Fargo
Wells Fargo
MaintainedOverweight56
5/8/2026
Wells Fargo
Wells Fargo
MaintainedOverweight56
5/8/2026
Truist Securities
Truist Securities
MaintainedBuy–
5/8/2026
RBC Capital
RBC Capital
MaintainedOutperform52
4/13/2026
Truist Securities
Truist Securities
MaintainedBuy–
3/2/2026
RBC Capital
RBC Capital
MaintainedOutperform52
1/7/2026
Wells Fargo
Wells Fargo
MaintainedOverweight56
12/2/2025
Truist Securities
Truist Securities
UpgradeHoldBuy–
11/18/2025
Wells Fargo
Wells Fargo
UpgradeEqual WeightOverweight56

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Pennant Group Earnings Calls

2025

Pennant Group Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/10/20260.34USD-294.39 MUSD-2026 Q2
5/11/20260.31USD-286.64 MUSD-2026 Q1
3/4/20260.32USD-280.48 MUSD-2025 Q4
5/2/20240.18USD-141.41 MUSD-2024 Q1
2/21/20240.22USD-139.16 MUSD-2023 Q4
8/7/20230.18USD-126.03 MUSD-2023 Q2
5/8/20230.15USD-121.63 MUSD-2023 Q1
2/27/20230.19USD-118.28 MUSD-2022 Q4
11/7/20220.19USD-116.91 MUSD-2022 Q3
8/8/20220.15USD-113.94 MUSD-2022 Q2

EESG©

Eulerpool ESG Scorecard© for the Pennant Group stock

22/100
4
Environment
23
Social
40
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Pennant Group shareholder structure

% Name
8.98821%
Van Berkom & Associates Inc.
Van Berkom & Associates Inc.
7.83631%
BLACKROCK, INC.
BLACKROCK, INC.
7.70177%
VAN BERKOM & ASSOCIATES INC.
VAN BERKOM & ASSOCIATES INC.
6.68879%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
5.89171%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
4.56671%
TURTLE CREEK ASSET MANAGEMENT INC.
TURTLE CREEK ASSET MANAGEMENT INC.
...

Pennant Group Beneficial Ownership Filings (SEC 13D/G)

Free Float
95.0%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
14.50%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
13.90%
85-4328500
85-4328500
SEC ↗
10.31%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
9.00%
Van Berkom & Associates Inc.
Van Berkom & Associates Inc.
SEC ↗
8.37%
Abigail P. Johnson
Abigail P. Johnson
SEC ↗
6.40%
Wasatch Advisors, Inc. 87-0319391
Wasatch Advisors, Inc. 87-0319391
SEC ↗
6.14%
Scott Green
Scott Green
SEC ↗
5.40%
Wasatch Advisors LP
Wasatch Advisors LP
SEC ↗
4.01%
8 Knots GP, LP
8 Knots GP, LP
SEC ↗
3.10%
FMR LLC
FMR LLC
SEC ↗

Pennant Group Executives and Management Board

12 members · avg. age 56 · 17 % women

BG

Mr. Brent Guerisoli (44)

Chairman of the Board, Chief Executive Officer · since 2021

2.59 M USD

Management

JG

Mr. John Gochnour (42)

President, Chief Operating Officer

2.06 M USD
LW

Ms. Lynette Walbom (47)

Chief Financial Officer

1.60 M USD
JS

Mr. Jason Steik (41)

Chief Clinical Officer

1.01 M USD
KC

Mr. Kirk Cheney (43)

Executive Vice President, General Counsel, Corporate Secretary

951,624.00 USD

Board of Directors

BS

Mr. Barry Smith (71)

Independent Director

615,014.00 USD
SL

Mr. Scott Lamb (62)

Lead Independent Director

357,660.00 USD
JN

Dr. John Nackel (73)

Independent Director

354,660.00 USD
GM

Mr. Gregory Morris (70)

Independent Director

347,160.00 USD
SC

Mr. Stephen Covey (62)

Independent Director

337,660.00 USD
CC

Mr. Christopher Christensen (56)

Independent Director

332,160.00 USD

Frequently asked questions about Pennant Group

The business model of Pennant Group Inc revolves around providing healthcare services to patients. As a leading provider of home health, hospice, and senior living services, Pennant Group Inc aims to enhance the quality of life for individuals by delivering personalized care and support. The company focuses on ensuring positive clinical outcomes and nurturing strong patient relationships. Pennant Group Inc continues to innovate and adapt its services to meet the evolving needs of its customers, while maintaining a commitment to compassionate and high-quality care.

Pennant Group Inc is primarily active in the healthcare industry.

The main competitors of Pennant Group Inc in the market include Kindred Healthcare, Amedisys Inc, and LHC Group Inc.

The Pennant Group Inc is a leading provider of healthcare services, focusing on home health, hospice, and senior living. With a rich history spanning several decades, Pennant Group Inc has established itself as a trusted name in the industry. Founded in 2019 and headquartered in Eagle, Idaho, the company has expanded its footprint nationwide, offering personalized care and support to individuals across the United States. Pennant Group Inc has a strong commitment to delivering high-quality services, fostering partnerships with healthcare professionals, and enhancing the well-being of their patients. With a dedicated team and a customer-centric approach, Pennant Group Inc continues to grow and excel in the healthcare sector.

Pennant Group Inc has achieved several significant milestones. The company has successfully expanded its services and geographic presence, establishing itself as a leading provider of home health, hospice, and senior living services. Pennant Group Inc has also demonstrated strong financial performance, with consistent revenue growth and improved margins. The company's solid track record has allowed it to attract and retain a talented team, ensuring the delivery of high-quality care to its patients. Pennant Group Inc continues to innovate and adapt to industry changes, positioning itself for future success and long-term value creation.

Pennant Group Inc is primarily present in the United States. They have an extensive presence throughout the country, offering their services in various states and regions. As a leading company in the healthcare industry, Pennant Group Inc provides high-quality care and services to patients across different states in the US. With a strong commitment to improving patient outcomes and delivering personalized care, Pennant Group Inc continues to expand its reach and impact in the healthcare sector.

Pennant Group Inc represents a strong commitment to providing exceptional healthcare services. With a focus on integrity, compassion, and teamwork, the company strives to improve lives through high-quality care. Pennant Group Inc emphasizes personalized attention, ensuring patients' needs are met with respect and dignity. Their corporate philosophy centers around fostering a supportive and inclusive environment for their employees, allowing them to deliver excellent care. By embracing innovation and clinical expertise, Pennant Group Inc aims to exceed patient expectations and create long-term value for their stakeholders.

Analysts currently set an average price target of 38.59 USD for the Pennant Group stock (median: 38.25 USD), implying -2.0 % versus the latest price. The consensus is based on 13 analyst ratings.

Pennant Group Analyst Price Targets 2026

13 analysts currently rate the Pennant Group stock: 12 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Pennant Group to generate revenue of 1.17 B USD and earnings per share of 1.32 USD.

Pennant Group Analyst Price Targets 2026

Converted at the current exchange rate, the Pennant Group share trades at 34.13 EUR (39.39 USD).

The Pennant Group share (PNTG) is listed on 3 stock exchanges, including: NASDAQ (PNTG), Frankfurt (1ZU.F), München (1ZU.MU).

The Pennant Group Inc. is a US-based company that operates in the healthcare sector. The company operates a network of care facilities and offers various services to support patients in their recovery, care, and assistance. In addition to providing care to patients in their homes, the Pennant Group Inc. also offers outpatient care and rehabilitation services, as well as hospice and palliative care. The Pennant Group operates in six different business segments: home care, employee health, hospice care, mobility support, rehab centers, and senior living. Each business segment specializes in meeting the needs of patients in various stages of health. An important aspect of Pennant Group's business model is collaboration with various healthcare facilities and insurance providers to provide seamless care to patients. By working closely with hospitals and rehabilitation clinics, Pennant Group can receive patients in their facilities and then smoothly transition them to outpatient care once their health allows. Another important offering is mobile care services. Medical services are provided through a mobile platform and application, allowing patients to manage their care providers and appointments. The Pennant Group also specializes in training caregivers and offering healthcare staffing services. The company benefits from the demand for qualified professionals in the healthcare industry and provides training and educational facilities to ensure caregivers stay up to date and improve their understanding of the latest medical and health developments. In summary, Pennant Group's business model focuses on a wide range of services that meet the needs of patients in various stages of health. Through collaboration with hospitals and rehabilitation clinics, as well as the use of mobile platforms and training facilities, the company has been able to expand its reach and secure an established marketplace. As the healthcare industry is a growing market segment, Pennant Group is well positioned to further expand its business and meet the demand for high-quality healthcare services.

The expected revenue of Pennant Group is 1.17 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Pennant Group is 46.94 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Pennant Group is currently 29.74. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Pennant Group stock.

The price-to-sales ratio (P/S) of Pennant Group is currently 1.20. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Pennant Group stock.

The Eulerpool Quality Score for Pennant Group is 5/10.

The ISIN of Pennant Group is US70805E1091. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Pennant Group is A2PRK9. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Pennant Group is PNTG. The ticker symbol is used to trade Pennant Group shares on the stock exchange.

Pennant Group paid dividends every year for the past 0 years.

Pennant Group is assigned to the 'Health' sector.

The dividends of Pennant Group are distributed in USD.

All fundamentals and in-depth analysis of Pennant Group

Our stock analysis for Pennant Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pennant Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Pennant Group Stock
Pennant Group Revenue→
Pennant Group Stock
Pennant Group Net Income→
Pennant Group Stock
Pennant Group P/E→
Pennant Group Stock
Pennant Group P/S→
Pennant Group Stock
Pennant Group EBIT→
Pennant Group Stock
Pennant Group Dividend→
Pennant Group Stock
Pennant Group Directors Dealings→
Pennant Group Stock
Pennant Group Stocks→
Pennant Group Stock
Pennant Group Market capitalization→
Pennant Group Stock
Pennant Group Debt→
Pennant Group Stock
Pennant Group Liabilities→
Pennant Group Stock
Pennant Group Equity→
Pennant Group Stock
Pennant Group AAQS→
Pennant Group Stock
Pennant Group Employees→
Pennant Group Stock
Pennant Group ROE→
Pennant Group Stock
Pennant Group ROA→
Pennant Group Stock
Pennant Group ROCE→
Pennant Group Stock
Pennant Group News→
Pennant Group Stock
Pennant Group Analyst Price Targets→

Health Stocks

Penta Valent Tbk PTPelthos TherapeuticsPentixapharm HoldingPeijia MedicalPenumbraPegBio CoPeopleBioPegavisionPepGenPediatrix Medical GroupPeptiDreamPeak ProcessingAll Stocks A–Z →